Trials / Sponsors / Li Zhiming
Li Zhiming
Academic / Other · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymp DLBCL - Diffuse Large B Cell Lymphoma, Chemo-free Therapy, Bispecific Antibody | Phase 2 | 2026-01-15 |
| Not Yet Recruiting | Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double- BTK Inhibitors, Histone Deacetylase Inhibitor, Double Express Diffuse Large B-cell Lymphoma | Phase 2 | 2025-06-01 |
| Recruiting | Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL Initial MZL, Untreated MZL, BTKi | Phase 2 | 2024-11-13 |
| Recruiting | Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma DLBCL Germinal Center B-Cell Type | Phase 2 | 2022-07-26 |